Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP407891.RARUeGwVkfmUnKP6-evLLX6TgipVbTGXlLelYRCtcEjIU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP407891.RARUeGwVkfmUnKP6-evLLX6TgipVbTGXlLelYRCtcEjIU130_assertion type Assertion NP407891.RARUeGwVkfmUnKP6-evLLX6TgipVbTGXlLelYRCtcEjIU130_head.
- NP407891.RARUeGwVkfmUnKP6-evLLX6TgipVbTGXlLelYRCtcEjIU130_assertion wasGeneratedBy ECO_0000203 NP407891.RARUeGwVkfmUnKP6-evLLX6TgipVbTGXlLelYRCtcEjIU130_provenance.
- NP407891.RARUeGwVkfmUnKP6-evLLX6TgipVbTGXlLelYRCtcEjIU130_assertion wasDerivedFrom befree-20150227 NP407891.RARUeGwVkfmUnKP6-evLLX6TgipVbTGXlLelYRCtcEjIU130_provenance.
- NP407891.RARUeGwVkfmUnKP6-evLLX6TgipVbTGXlLelYRCtcEjIU130_assertion SIO_000772 24468836 NP407891.RARUeGwVkfmUnKP6-evLLX6TgipVbTGXlLelYRCtcEjIU130_provenance.
- NP407891.RARUeGwVkfmUnKP6-evLLX6TgipVbTGXlLelYRCtcEjIU130_assertion evidence source_evidence_literature NP407891.RARUeGwVkfmUnKP6-evLLX6TgipVbTGXlLelYRCtcEjIU130_provenance.
- NP407891.RARUeGwVkfmUnKP6-evLLX6TgipVbTGXlLelYRCtcEjIU130_assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407891.RARUeGwVkfmUnKP6-evLLX6TgipVbTGXlLelYRCtcEjIU130_provenance.